Relationship between plasma TNF-α levels and agitation symptoms in first episode patients with schizophrenia

Xiaoying Wang,Wenjin Chen,Mengzhuang Gou,Wei Li,Na Li,Jinghui Tong,Yanfang Zhou,Ting Xie,Ting Yu,Wei Feng,Yanli Li,Song Chen,Baopeng Tian,Shuping Tan,Zhiren Wang,Shujuan Pan,Xingguang Luo,Ping Zhang,Junchao Huang,Li Tian,Chiang-Shan R. Li,Yunlong Tan

DOI: https://doi.org/10.1186/s12888-024-05796-y

IF: 4.144

2024-07-02

BMC Psychiatry

Abstract:Abstract Background Increasing evidence suggested that immune abnormalities involved in the pathophysiology of schizophrenia. However, the relationship between immunity and clinical features has not been clarified. The aim of this study was to measure the plasma levels of tumor necrosis factor alpha (TNF-α) and soluble TNF-α receptor 1 (sTNF-α R1) and to investigate their association with agitation in first episode patients with schizophrenia (FEPS). Methods The plasma TNF-α and sTNF-α R1 levels were measured using sandwich enzyme-linked immunosorbent assay (ELISA) in the FEPS with ( n = 36) and without agitation ( n = 49) symptoms, and healthy controls (HCs, n = 54). The psychopathology was assessed by the Positive and Negative Syndrome Scale (PANSS), and the agitation symptoms were evaluated by the PANSS excitatory component (PANSS-EC). Results The plasma TNF-α levels in patients with and without agitation symptoms were significantly higher than those in HCs. The patients with agitation had significantly higher plasma TNF-α levels compared to the patients without agitation. There were no significant differences in the sTNF-α R1 levels among the three groups. Furthermore, the plasma TNF-α levels were positively correlated with the PANSS total score, Positive and General psychopathological subscores, and PANSS-EC score in the FEPS, but the relationships were not found for the plasma sTNF-α R1 levels. Conclusions These results suggested that TNF-α might play an important role in the onset and development of agitation symptoms of schizophrenia.

psychiatry